Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Complete blood count and ferritin for anemia diagnosis in pregnancy with oral ferrous sulfate response assessment
RBR-237wbgPhase 3Recruiting
- Sponsor
- National Council for Scientific and Technological Development
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ferrous sulfate in anaemia and iron deficiency anemia (IDA), sponsored by National Council for Scientific and Technological Development. Primary endpoints: Change in hemoglobin after oral iron treatment and Final diagnosis of functional iron deficiency. Started Aug 2011; status: recruiting.
02
Drugs
ferrous sulfate
03
Conditions
anaemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on RBR-237wbg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-237wbg.